ENTRADA THERAPEUTICS, INC.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About TRDA
Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in establishing a class of medicines, which engages intracellular targets. Its Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the delivery of a range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The Company is advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others. It is engaged in preclinical lead optimization efforts in both neuromuscular and non-neuromuscular disease and discovery efforts to advance platform applications. Its lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
Find out what a historical investment in ENTRADA THERAPEUTICS, INC. would be worth today using our TRDA stock calculator.
$273.64M
-
0.00%
58.03K
$7.41
$7.10
$7.20
$21.79
$7.10
Ready to start your investing journey with Stake?
Open an accountTRDA FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in TRDA
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in TRDA
on Stake
Buy TRDA from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of TRDA from only US$10 with fractional shares
